Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00895
|
|||||
| Drug Name |
Chlorambucil
|
|||||
| Synonyms |
Ambochlorin; Amboclorin; C0253; CB 1348; CB-1348; CB1348; Cb l348; Chlocambucil; Chloorambucol; Chlorambucil (USP/INN); Chlorambucil [INN:BAN]; Chlorambucilum; Chlorambucilum [INN-Latin]; Chloraminophen; Chloraminophene; Chlorbutin; Chlorbutine; Chlorbutinum; Chloroambucil; Chlorobutin; Chlorobutine; Clorambucile; Clorambucile [DCIT]; Clorambucilo; Clorambucilo [INN-Spanish]; Ecloril; Elcoril; Elcorin; Glaxo Wellcome Brand of Chlorambucil; GlaxoSmithKline Brand of Chlorambucil; LEUKERAN (TN); Leuk ersan; Leukeran; Leukeran (TN); Leukeran tablets; Leukersan; Leukoran; Linfolizin; Linfolysin; Lympholysin; Phenylbuttersaeure-lost; Phenylbuttersaeure-lost[German]; Phenylbutyric acid nitrogen mustard; Wellcome Brand of Chlorambucil
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Chronic lymphocytic leukemia [ICD11: 2A82.0] | Approved | [1] | |||
| Therapeutic Class |
Anticancer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H19Cl2NO2
|
|||||
| Canonical SMILES |
C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
|
|||||
| InChI |
InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)
|
|||||
| InChIKey |
JCKYGMPEJWAADB-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 305-03-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 304.2 | Topological Polar Surface Area | 40.5 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
1.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:28830
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1A2 | Transporter Info | Organic anion transporting polypeptide 1A2 | Substrate | [2] | |
| P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [3] | ||
| References | ||||||
| 1 | Chlorambucil was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Transporters and renal drug elimination. Annu Rev Pharmacol Toxicol. 2004;44:137-66. | |||||
| 3 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.